FR8090M - - Google Patents

Info

Publication number
FR8090M
FR8090M FR172421A FR172421A FR8090M FR 8090 M FR8090 M FR 8090M FR 172421 A FR172421 A FR 172421A FR 172421 A FR172421 A FR 172421A FR 8090 M FR8090 M FR 8090M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR172421A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19671617356 external-priority patent/DE1617356C/de
Application filed filed Critical
Application granted granted Critical
Publication of FR8090M publication Critical patent/FR8090M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR172421A 1967-09-05 1968-11-04 Expired FR8090M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19671617356 DE1617356C (de) 1967-09-05 1967-09-05 Stabiler, oral zu verabreichender Poliomyelitis-Impfstoff

Publications (1)

Publication Number Publication Date
FR8090M true FR8090M (fr) 1970-07-20

Family

ID=5682272

Family Applications (1)

Application Number Title Priority Date Filing Date
FR172421A Expired FR8090M (fr) 1967-09-05 1968-11-04

Country Status (4)

Country Link
US (1) US3629399A (fr)
ES (1) ES357848A1 (fr)
FR (1) FR8090M (fr)
GB (1) GB1243252A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7803891A (en) * 1978-04-12 1979-10-16 Merck & Co Inc Preservatives for vaccines - contg. hydrolysed gelatin, sorbitol, culture medium and a buffer at pH 6-6.5

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
WO2007132480A2 (fr) * 2006-05-12 2007-11-22 Bharat Biotech International Limited Composition utilisée comme vaccin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7803891A (en) * 1978-04-12 1979-10-16 Merck & Co Inc Preservatives for vaccines - contg. hydrolysed gelatin, sorbitol, culture medium and a buffer at pH 6-6.5

Also Published As

Publication number Publication date
US3629399A (en) 1971-12-21
GB1243252A (en) 1971-08-18
ES357848A1 (es) 1970-04-01

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
FR8090M (fr)
AU416737B2 (fr)
AU2277767A (fr)
AU342066A (fr)
AU610966A (fr)
AU2116667A (fr)
AU2256867A (fr)
AU3151267A (fr)
AU1273466A (fr)
AU2454867A (fr)
AU3189468A (fr)
AU2528767A (fr)
AU2977667A (fr)
BE692779A (fr)
BE514578A (fr)
AU25066A (fr)
BE692778A (fr)
AU34866A (fr)
AU408412B2 (fr)
AU2406369A (fr)
AU23366A (fr)
AU459699A (fr)
AU1868267A (fr)
AU1763766A (fr)